Key Stories from the past week: Stocks climb on trade war optimism

Key Stories from the past week: Stocks climb on trade war optimism

Macro
Saxo Be Invested
Saxo

It has been the busiest week of the earnings season with 180 companies from S&P500 and 91 companies Euro Stoxx 600 reporting. Overall earnings continue to look solid, while the near-term outlook looks cloudier as tariff concerns still dominate headlines.


Big week of reporting from Big Tech
Microsoft, Meta, Amazon and Apple all reported this week setting the tone for investor confidence across the globe and boosting US benchmarks. AI spend remains a focus with no signs of capex fatigue, but tariff risks encourage caution.
Big Tech Earnings

Obesity drug war intensifies
Eli Lilly sales soared 45% on weight loss drug demand, but the shares still fell 12% as CVS Health Corp announced a plan to drop Lilly weight-loss drug Zepbound from its preferred list, making rival Novo Nordisk’s Wegovy more widely available.
Novo Nordisk strike back

Tariff uncertainty blights the car manufacturers
General Motors Q1 results beat estimates but the car maker is forced to suspend guidance and pause buybacks due to tariff uncertainty. Stellantis and Mercedes-Benz follow General Motors in deciding to withdraw outlooks. Volkswagen, who reported an earnings drop of 40% YoY, did offer a forecast of 5% sales growth in 2025. This does not include any impact from tariffs recently announced.
Trump softens blow of automotive tariffs

Market activity boosts bank earnings
Several European banks published strong Q1 earnings aided by recent market volatility and through cost saving measures. HSBC reported Q1 pretax profit $9.48bn, above estimates, with $3bn buyback and restructuring to save $1.8bn over two years. Deustche Bank reported highest profit in 14 years with the group is on track for delivery on all 2025 targets. Other banks to beat were UBS, Soc Gen, ING Groep, Barclays, Standard Chartered.
UBS profit boosted by 'huge' spike in client activity, but uncertainty looms


Next week markets will zero in on policy rate decisions from the Fed on Wednesday and BoE of Thursday. The former is expected hold steady, while the latter is fully priced for a 25bps cut. China will publish a trade report on Friday which will likely show an initial hit from the escalating trade war. Earnings season also rolls on with the like of Palantir on Monday, AMD on Tuesday, and Novo Nordisk, Uber, Disney and Arm Holdings all on Wednesday.

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992